Clinical Trial: Study of the Subdermal Implant "Algeness"

U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07618468) titled 'Study of the Subdermal Implant "Algeness"' on May 25.

Brief Summary: A single-center clinical study of the efficacy and safety of the medical device "Algeness subdermal implant based on agarose (Ghimas SpA/Ghimas SpA, Italy) in the correction of skin contour defects.

Study Start Date: June 08, 2024

Study Type: INTERVENTIONAL

Condition: Skin Aging Facial Wrinkles Soft Tissue Volume Loss Lipoatrophy

Intervention: DEVICE: Algeness Subdermal Implant (Agarose)

Slowly absorbable biocompatible hydrogel based on natural agarose (1.0-3.5%) with phosphate buffer. Four formulations: LD (1%), HD (1.5%), VL (2.5% with hyaluronate), DF (3.5...